Because breasts are largely made up of fat, losing weight can naturally lead to a smaller, less firm, or looser appearance of the breasts
Not recommended for regular use with GLP-1 medications
Sine wave pattern cardiac arrest Not all patients show ECG changes
Bioavailability Injectable semeglutide has a high bioavailability and can more effectively exert its drug effects, thereby achieving therapeutic effects such as reducing blood sugar and weight
However, if you are high risk for heart disease, have had a heart event or the equivalent (stroke, stent), or do not require 15-20% weight loss, semaglutide / Wegovy may be a better choice
You can fine-tune your dose to the exact milligram if your provider thinks that will improve your results or reduce side effects